Highlights
A collection of news and information related to MedImmune Inc. published by this site and its partners.
Displaying items 1-12 of 33
» View courant.com items only
1
2
3
•
Next >
-
AstraZeneca closes in on site for new home in Cambridge
Reuters* Drugmaker eyes Cambridge Biomedical Campus - sources * Relocation centrepiece of new CEO's restructuring plan * New research centre and corporate HQ to cost some $500 mln By Ben Hirschler and Tom Bill LONDON, May 20 (Reuters) - AstraZeneca is...Tags: Cheshire, Biology, Elizabeth II, University of Cambridge, AstraZeneca Plc
-
Grotech Ventures chosen to invest state money in Maryland startups
Grotech Ventures will be the first venture capital firm to invest in Maryland startup companies using $12 million in state money as part of the InvestMaryland program, state economic development officials said Wednesday. The firm was selected based on...Tags: Timonium, Politics, Entertainment, Auction Service, Tax Credits
-
MedImmune creating drug pipeline for AstraZeneca
When Gail Folena-Wasserman joined Gaithersburg biotechnology startup MedImmune in 1991, she was its first employee in research and development, and dreamed of what the company might be "when it grew up."
Two decades later, the senior vice president for...Tags: Lilly Eli & Co, Financial Markets, Food and Drug Administration, Stock Market, FluMist (vaccine)
-
Industrial employment in Baltimore-Washington area falls 2.3%
Industrial employment in Maryland and Washington, D.C., fell 2.3 percent in a year-over-year period ending in May, with layoffs at defense contractor AAI Corp. and the closure of the Solo Cup plant in Owings Mills contributing to job losses,...Tags: Howard County, Industrial Production, General Motors Corp., Career and Workplace, Manufacturing and Engineering
-
GlaxoSmithKline to acquire Human Genome Sciences
After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
GlaxoSmithKline boosted its offer for...Tags: Patents, Copyrights and Trademarks, Immune System, Food and Drug Administration, Heart Disease, Drugs and Medicines
-
FDA approves new flu vaccine
The U.S. Food and Drug Administration has approved a new vaccine to prevent the seasonal flu.
FluMist Quadrivalent is the first vaccine to contain four strains of the influenza virus - two influenza A strains and two B strains. It is manufactured by...Tags: Chemical Industry, Health, Preventative Medicine, Flu, Viral Diseases and Infections
-
Maryland raises $84 million to invest in tech startups
Maryland succeeded in raising $84 million to invest in promising technology companies across the state via a novel online auction of tax credits, officials announced Thursday. The InvestMaryland plan, a cornerstone of Gov. Martin O'Malley's legislative...Tags: Barack Obama, Finance, Politics, Insurance, Computing and Information Technology Industry
-
State biotech firms hope Congress will act
A proposal to speed the approval of new prescription drugs has patient advocates and biotech firms — including many based in Maryland — hoping that Congress will deliver a rare dose of bipartisanship this year.
Lawmakers are proposing a 6...Tags: Politics, U.S. House of Representatives, Lobbying, U.S. House Committee on Energy and Commerce, Symptoms
-
Report: Clinical trials of new medications help create jobs in Maryland
Maryland has hosted 1,775 clinical trials for new medicines targeting six major chronic diseases since 1999, including 369 that are still in the early stages of recruiting patients, according to a study by two pharmaceutical industry groups released...Tags: Politics, University of Maryland Medical Center, Heart Disease, Hospitals and Clinics, Jack Markell
-
Consolidation wave poised to hit state's health care services, biopharma sectors
Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals. Both homegrown companies — Human Genome Sciences Inc. and Catalyst...Tags: Montgomery (Kane, Illinois), Stock Market, Lockheed Martin Corp., Express Scripts Incorporated, Companies and Corporations
-
Time for flu shots, and some may get a tiny needle
WASHINGTON — It’s flu vaccine time again — and some lucky shot-seekers will find that the needle has shrunk.
The first flu shot that works with a less-scary skin prick instead of an inch-long needle is hitting the market this fall....Tags: Allergies, Chemical Industry, Health, Preventative Medicine, Flu
-
Maryland's biotech pitch: We know the Feds
In a conference room in downtown Baltimore, F. Blix Winston compared the Food and Drug Administration to a "slow-moving bulldog."
"You don't want to get bitten," Winston, an expert on the federal regulation of medical devices, told a crowd of about 50...Tags: Politics, Food and Drug Administration, National Government, Health Organizations, Fort Detrick (military base)
May 20, 2013
|Story| Reuters
Dec 5, 2012
|Story| Baltimore Sun
Nov 18, 2012
|Story| Baltimore Sun
Jul 16, 2012
|Story| Baltimore Sun
Jul 16, 2012
|Story| Baltimore Sun
Mar 1, 2012
|Story| Baltimore Sun
Mar 15, 2012
|Story| Baltimore Sun
May 5, 2012
|Story| Baltimore Sun
May 18, 2012
|Story| Baltimore Sun
Apr 21, 2012
|Story| Baltimore Sun
Sep 13, 2011
|Story| Petoskey News
Jul 5, 2011
|Story| Baltimore Sun
Original site for MedImmune Inc. topic gallery.
